Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis
Clinical trial NCT04725136 · UNKNOWN
Trial details
- NCT number
- NCT04725136
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2023-01-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.